This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of ear and external auricular canal
CD2_INSITU_SKIN_EAR_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis auriculae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of ear and external auricular canal
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of ear and external auricular canal
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 451 | 55 | 396 |
| Unadjusted period prevalence (%) | 0.16 | 0.02 | 0.17 |
| Median age at first event (years) | 78.48 | 74.91 | 78.98 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 382
- Matched controls
- 3819
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
+∞
323.0
382
*
L57.0
ICD-10 Finland
Actinic keratosis
60.2
225.7
280
166
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
76.5
171.7
191
49
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
40.3
164.2
215
118
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
738.0
154.3
142
*
TQW99
NOMESCO Finland
Other minor procedure on skin
44.6
121.7
151
55
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
84.7
107.7
118
20
R23.8
ICD-10 Finland
Other and unspecified skin changes
14.0
87.8
168
203
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
29.1
86.9
120
59
DAB00
NOMESCO Finland
Excision of lesion of auricle
267.9
85.1
84
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
157.8
83.9
86
7
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
81.2
75
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
941.9
80.5
76
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
911.1
78.2
74
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
66.6
62
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
64.4
60
*
D06BB10
ATC
imiquimod; topical
21.8
60.7
91
54
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
60.0
56
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
57.8
54
*
S18
ICPC
Laceration/cut
6.0
57.7
261
1013
ZQZ00
NOMESCO Finland
Treatment of several skin areas
+∞
56.7
53
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
139.0
56.6
59
5
ZZR00
NOMESCO Finland
Flap of skin
90.1
55.9
61
8
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
609.9
55.0
53
*
ZXC50
NOMESCO Finland
Cryotherapy
27.6
55.0
76
34
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
160.0
53.4
55
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
29.3
53.0
72
30
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
50.1
47
*
ZXC20
NOMESCO Finland
Use of chemical agents
36.3
49.9
64
21
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
119.9
49.1
52
5
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
17.9
48.7
78
54
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
22.3
47.5
70
38
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
479.4
44.1
43
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
91.3
44.0
48
6
ZXC15
NOMESCO Finland
Use of photodynamic technique
49.9
43.5
52
12
Z2221
NOMESCO Finland
Medical doctor
5.1
43.3
176
546
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
38.2
36
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
36.0
34
*
ZXD10
NOMESCO Finland
Scheduled procedure
4.0
34.8
206
868
L82
ICD-10 Finland
Seborrhoeic keratosis
5.5
33.5
113
271
Z3231
NOMESCO Finland
Registered nurse
4.0
32.3
167
615
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
21.2
31.8
47
25
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
31.7
30
*
116
Kela drug reimbursment
Prostate cancer
+∞
30.6
29
*
J01DB01
ATC
cefalexin; oral
4.3
29.1
323
2143
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
29.9
28.6
38
14
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
22.8
28.5
41
20
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
28.5
27
*
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
156.4
28.0
29
*
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
32.9
27.8
36
12
ZXE00
NOMESCO Finland
One hour or less
3.4
27.5
194
887
WX110
NOMESCO Finland
Local anesthesy
3.3
26.9
252
1410
SPAT1153
SPAT
Removal of sutures
3.5
26.9
176
757
ZXA00
NOMESCO Finland
Right side
3.5
25.9
161
660
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
24.2
227
1229
130
Kela drug reimbursment
Malignant tumour
+∞
24.2
23
*
127
Kela drug reimbursment
Transplant complication
28.9
24.0
32
12
A98
ICPC
Health maint/preventive medicine
4.4
23.7
342
2520
WX002
NOMESCO Finland
Sedation and analgesia
3.7
23.6
123
433
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
23.1
178
835
Z94.0
ICD-10 Finland
Kidney transplant status
31.2
22.2
29
10
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
22.1
21
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
232.7
21.8
22
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
63.8
21.1
24
*
S21
ICPC
Skin texture symptom/complaint
4.2
20.9
87
248
XQ848
NOMESCO Finland
Dermatological photography
14.7
20.9
35
26
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
21.6
20.7
30
15
S29
ICPC
Skin symptom/complaint other
3.9
20.4
96
306
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
20.0
19
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
210.3
19.7
20
*
N02BE01
ATC
paracetamol; systemic, rectal
3.5
19.7
328
2430
R4110
NOMESCO Finland
Physiotherapy
3.2
19.3
126
514
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
105.2
18.7
20
*
JN4BD
NOMESCO Finland
Extensive body CT
6.6
18.6
49
83
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
18.4
120
484
L04AA06
ATC
mycophenolic acid; systemic
17.7
18.1
28
17
DHB00
NOMESCO Finland
Excision of lesion of external nose
55.3
18.1
21
*
L04AD01
ATC
ciclosporin; systemic
19.2
18.0
27
15
ZXA05
NOMESCO Finland
Left side
2.9
18.0
143
658
E0000UV
ATC
NA
2.8
17.9
157
768
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
30.4
17.6
23
8
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
16.8
16
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
16.8
16
*
D06BX02
ATC
ingenol mebutate; topical
19.6
16.2
24
13
ZX120
NOMESCO Finland
Intravenous
4.8
16.0
56
133
Z3226
NOMESCO Finland
Physiotherapist
3.2
16.0
96
363
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
12.5
15.8
28
24
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
88.8
15.7
17
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.2
15.3
34
45
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.0
15.2
104
427
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
59.1
14.9
17
*
L02BB03
ATC
bicalutamide; oral
+∞
14.7
14
*
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
14.7
14
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.4
14.4
44
90
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.8
14.4
41
77
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.1
14.0
29
34
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
31.4
14.0
18
6
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
10.3
13.9
27
28
B01AB05
ATC
enoxaparin; parenteral
2.6
13.9
130
640
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.8
13.7
102
438
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.6
13.7
35
57
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
78.0
13.7
15
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
13.6
13
*
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
+∞
13.6
13
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
13.6
13
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
13.3
74
263
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
13.2
116
549
XKD00
NOMESCO Finland
Uroflowmetry
2.6
13.2
120
580
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
13.0
62
196
ZZA00
NOMESCO Finland
Split skin graft
7.5
12.8
30
43
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
12.6
12
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
12.6
12
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
134.2
12.5
13
*
WF002
NOMESCO Finland
Radical radiotherapy
134.2
12.5
13
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
12.2
89
377
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
8.5
11.8
25
31
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
31.1
11.7
15
5
Z2446
NOMESCO Finland
Social worker
4.8
11.6
39
89
H81
ICPC
Excessive ear wax
2.5
11.6
101
473
A12AA04
ATC
calcium carbonate; oral
7.4
11.5
27
39
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
11.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
11.5
11
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
11.5
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
123.5
11.5
12
*
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
123.5
11.5
12
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.3
11.4
125
657
S77
ICPC
Malignant neoplasm of skin
36.2
11.3
14
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.9
11.2
75
300
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
25.9
11.2
15
6
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.3
11.1
29
49
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
10.6
134
747
A03FA01
ATC
metoclopramide; systemic, rectal
3.5
10.6
51
162
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
10.6
38
93
WF003
NOMESCO Finland
Adjuvant radiotherapy
112.9
10.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.5
10
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
10.4
100
488
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
10.2
156
943
B01AB10
ATC
tinzaparin; parenteral
4.8
10.2
33
73
JN4AD
NOMESCO Finland
Body CT examination
5.2
10.2
31
64
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.5
10.1
19
19
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.5
10.1
19
19
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
10.1
62
234
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
10.1
112
587
L17
ICPC
Foot/toe symptom/complaint
2.3
10.1
106
541
A11CC03
ATC
alfacalcidol; systemic
5.5
10.1
29
56
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
41.2
10.0
12
*
L03
ICPC
Low back symptom/complaint
2.5
10.0
87
405
TQW80
NOMESCO Finland
Local dermatologic skincare
6.8
9.9
24
37
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.6
9.8
76
330
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.1
9.8
23
34
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
9.7
201
1366
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
11.8
9.7
17
15
TQW40
NOMESCO Finland
Remowal of suture of skin
4.4
9.6
34
82
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
9.6
63
249
TK800
NOMESCO Finland
Hemodialysis
6.5
9.5
24
39
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
9.5
156
966
J01CA04
ATC
amoxicillin; systemic
2.0
9.5
266
2021
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
9.4
9
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
22.3
9.4
13
6
XW000
NOMESCO Finland
Bone marrow biopsy
5.4
9.3
27
53
S82
ICPC
Naevus/mole
3.2
9.2
48
162
UKC02
NOMESCO Finland
Cystoscopy
2.3
9.2
99
509
Z49.0
ICD-10 Finland
Preparatory care for dialysis
10.4
9.1
17
17
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
9.1
269
2070
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.5
9.1
26
50
WW500
NOMESCO Finland
Blood transfusion
5.7
9.1
25
46
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
37.6
9.1
11
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.9
8.9
15
12
L04AA01
ATC
[U] ciclosporin; systemic
14.5
8.8
14
10
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.3
8.7
86
423
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
3.4
8.7
42
134
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
8.6
154
975
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
10.4
8.6
16
16
A02BC02
ATC
pantoprazole; systemic
1.9
8.6
233
1717
S15
ICPC
Foreign body in skin
3.8
8.5
36
103
D07AB08
ATC
desonide; topical
3.1
8.5
47
163
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.8
8.5
27
59
M79.6
ICD-10 Finland
Pain in limb
2.1
8.5
122
711
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
92.0
8.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
92.0
8.4
9
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
92.0
8.4
9
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.0
8.4
26
55
D03.5
ICD-10 Finland
Melanoma in situ of trunk
+∞
8.4
8
*
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.4
8
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
8.4
8
*
Z51.5
ICD-10 Finland
Palliative care
4.8
8.4
27
60
H02AB02
ATC
dexamethasone; systemic
14.9
8.3
13
9
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
8.2
160
1041
WX320
NOMESCO Finland
Spinalanesthesy
2.2
8.2
96
510
ZXD05
NOMESCO Finland
Urgent procedure
2.0
8.2
135
828
N02AX02
ATC
tramadol; systemic, rectal
1.9
8.1
160
1046
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
12.1
8.1
14
12
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
8.1
61
261
Z71.8
ICD-10 Finland
Other specified counselling
2.3
8.0
77
372
SAA02
NOMESCO Finland
Basic examination of mouth
1.9
8.0
169
1133
N18.0
ICD-10 Finland
End-stage renal disease
7.2
7.9
18
26
H02AB04
ATC
methylprednisolone; systemic
2.4
7.8
67
307
D07AC01
ATC
betamethasone; topical
1.9
7.7
132
815
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
45.9
7.7
9
*
ZZA50
NOMESCO Finland
Full thickness skin graft
45.9
7.7
9
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.8
7.7
182
1259
C07AB07
ATC
bisoprolol; oral
1.8
7.7
232
1741
KMAK
NOMESCO Finland
NA
1.9
7.6
145
929
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.5
7.5
62
276
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.0
7.5
118
706
Y77
ICPC
Malignant neoplasm prostate
81.6
7.4
8
*
H25.1
ICD-10 Finland
Senile nuclear cataract
1.9
7.4
152
1000
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
7.4
79
400
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.5
7.4
25
59
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
7.3
7
*
SPAT1211
SPAT
Application of soft bandage
2.9
7.2
45
170
L60.0
ICD-10 Finland
Ingrowing nail
4.7
7.2
23
51
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
30.6
7.2
9
*
WXQ99
NOMESCO Finland
Other light therapy
30.6
7.2
9
*
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
30.6
7.2
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
7.2
114
680
S26
ICPC
Fear of cancer of skin
12.3
7.1
12
10
3AC01
NOMESCO Finland
NA
12.3
7.1
12
10
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.1
156
1046
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
7.0
118
720
207
Kela drug reimbursment
Chronic arrhythmias
2.0
7.0
95
536
CBN30
NOMESCO Finland
Shortening of canthal ligament
14.1
6.9
11
8
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
6.9
80
421
XQ845
NOMESCO Finland
Dermatoscopy
11.2
6.8
12
11
N18.8
ICD-10 Finland
Other chronic renal failure
3.8
6.8
27
74
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.1
6.8
87
478
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
40.8
6.8
8
*
ZXA10
NOMESCO Finland
Bilateral
2.1
6.8
85
463
WX402
NOMESCO Finland
General anaesthesia
2.8
6.8
43
166
M54.5
ICD-10 Finland
Low back pain
2.0
6.8
100
578
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
23.0
6.7
9
*
H26.4
ICD-10 Finland
After-cataract
2.4
6.7
57
259
A04AA01
ATC
ondansetron; systemic, rectal
8.0
6.7
14
18
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
6.7
151
1015
N40
ICD-10 Finland
Hyperplasia of prostate
1.8
6.6
172
1208
TQW40
SPAT
NA
5.2
6.6
19
38
S97
ICPC
Chronic ulcer skin
2.9
6.6
38
139
N02AA05
ATC
oxycodone; systemic
2.3
6.4
60
286
R52.0
ICD-10 Finland
Acute pain
8.4
6.4
13
16
XF404
NOMESCO Finland
Ambulatory ECG
2.4
6.4
55
252
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.8
6.3
158
1095
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
6.3
6
*
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
+∞
6.3
6
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
6.3
6
*
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C44.2
ICD-10 Finland
Malignant neoplasm: Skin of ear and external auricular canal
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
6.3
6
*
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
3.1
6.3
33
114
H02.1
ICD-10 Finland
Ectropion of eyelid
5.2
6.3
18
36
J05AB11
ATC
valaciclovir; oral
2.6
6.3
46
192
G04CA02
ATC
tamsulosin; oral
1.7
6.2
176
1261
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
6.2
26
75
B03XA02
ATC
darbepoetin alfa; parenteral
5.5
6.2
17
32
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.4
6.2
21
50
B07.9
ICD-10 Finland
Verruca simplex
5.9
6.2
16
28
-59
ICPC
Other therap proced/minor surg NEC
5.9
6.2
16
28
D01AE16
ATC
amorolfine; topical
2.4
6.2
54
248
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
6.2
22
55
M04AA01
ATC
allopurinol; systemic
2.0
6.2
88
503
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
6.2
142
957
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
6.1
89
511
Z02.4
ICD-10 Finland
Examination for driving licence
1.8
6.1
137
913
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
6.0
35
128
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
217
214
18.62
211.50
2.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
357
788
17.94
191.64
5.1
1.6
—
—
—
0
0
(4035726)
81
73
13.31
79.24
1.6
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
306
1570
3.95
42.26
10.3
5.1
e9/l
4.6
4.7
0.25
260
1349
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
130
382
4.38
40.61
4.1
2.5
u/l
241.1
240.2
0.03
122
354
(3006315) Basophils [#/volume] in Blood
277
1421
3.46
36.30
7.7
4.4
e9/l
0.0
0.0
0.34
234
1208
(3019198) Lymphocytes [#/volume] in Blood
279
1438
3.47
36.27
7.7
4.5
e9/l
2.0
1.7
1.06
237
1234
(3013115) Eosinophils [#/volume] in Blood
282
1464
3.47
36.21
8.4
4.5
e9/l
0.2
0.2
1.09
241
1252
(3001604) Monocytes [#/volume] in Blood
274
1411
3.40
35.38
7.8
4.4
e9/l
0.7
0.6
0.20
234
1189
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
369
2302
4.32
34.86
10.4
5.0
u/l
88.0
79.5
1.13
349
2086
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
141
489
3.74
34.28
4.1
2.5
%
21.8
21.8
0.01
131
414
(3004789) Transferrin [Mass/volume] in Serum or Plasma
146
520
3.67
34.08
3.8
2.4
g/l
2.1
2.2
0.48
135
471
(3019069) Monocytes/100 leukocytes in Blood
260
1323
3.28
33.76
8.7
4.9
%
9.1
9.0
0.24
243
1206
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
284
1522
3.34
33.76
6.9
3.7
umol/l
15.1
13.8
0.48
270
1420
(3024561) Albumin [Mass/volume] in Serum or Plasma
268
1392
3.28
33.52
7.0
3.6
g/l
33.2
34.3
2.21
254
1271
(3018010) Neutrophils/100 leukocytes in Blood
259
1326
3.24
33.07
8.1
4.7
%
59.1
60.1
0.52
239
1208
(3002030) Lymphocytes/100 leukocytes in Blood
259
1340
3.19
32.21
8.6
4.8
%
25.4
24.1
0.82
241
1209
(3006504) Eosinophils/100 leukocytes in Blood
256
1318
3.18
32.07
8.4
4.6
%
2.8
3.0
0.63
237
1197
(3022096) Basophils/100 leukocytes in Blood
248
1275
3.10
30.77
8.5
4.6
%
0.6
0.6
0.04
232
1167
(42870588) Differential panel, method unspecified - Blood
206
966
3.08
29.90
7.9
4.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
166
690
3.22
29.68
3.7
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
411
2921
5.59
28.95
30.0
16.6
mg/l
28.8
29.3
0.10
368
2377
(3044640) Blood type and Crossmatch panel - Blood
196
908
3.05
28.86
3.8
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
390
2684
4.35
28.36
29.1
15.4
ml/min/173m2
61.5
68.6
7.80
353
2185
(3022948) Iron [Moles/volume] in Serum or Plasma
147
583
3.26
28.25
3.9
2.4
umol/l
11.3
11.9
0.52
138
527
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
237
1230
2.95
28.20
5.7
3.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
285
1635
3.02
28.14
11.9
5.5
mmol/l
1.2
1.2
0.71
252
1370
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
274
1541
2.98
28.02
2.6
2.2
pmol/l
91.3
90.1
0.15
158
847
(40758558) Short blood count panel - Blood
157
656
3.14
27.51
8.9
4.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
166
720
3.07
27.20
6.3
3.5
%
72.4
75.5
0.74
166
702
(3013826) Glucose [Moles/volume] in Serum or Plasma
315
1954
3.03
26.13
6.5
4.5
mmol/l
6.8
7.0
0.99
299
1850
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
414
3048
5.37
25.63
15.4
9.2
u/l
23.3
24.1
0.56
402
2867
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
262
1501
2.78
24.81
10.2
5.1
mmol/l
1.2
1.2
0.75
240
1325
(3015377) Calcium [Moles/volume] in Serum or Plasma
205
1039
2.78
24.67
3.7
2.0
mmol/l
2.3
2.3
0.04
165
839
(40768443) Skin Pathology biopsy report
54
115
5.20
24.53
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
419
3157
5.61
24.08
42.8
23.7
e9/l
210.8
226.0
4.52
410
3032
(3026361) Erythrocytes [#/volume] in Blood
419
3158
5.61
24.04
42.9
23.7
e12/l
4.3
4.4
5.43
409
3012
(3010813) Leukocytes [#/volume] in Blood
419
3159
5.60
24.01
42.9
23.8
e9/l
7.4
7.1
0.96
411
3015
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
77
223
3.96
23.70
2.3
2.2
u/l
27.3
29.9
0.66
66
171
(3023103) Potassium [Moles/volume] in Serum or Plasma
416
3130
5.24
23.64
36.7
20.9
mmol/l
4.1
4.0
0.38
411
3021
(3003458) Phosphate [Moles/volume] in Serum or Plasma
121
474
3.12
23.24
12.5
4.5
mmol/l
1.0
1.0
0.49
116
429
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
128
521
3.03
22.96
4.2
2.8
e6/l
0.9
1.2
0.35
81
297
(3021589) Normoblasts [#/volume] in Blood
228
1258
2.64
22.66
13.7
8.5
e9/l
0.0
0.0
0.01
187
1022
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
205
3.99
22.65
2.0
1.7
g/l
1.5
1.5
0.05
64
170
(3026493) Urate [Moles/volume] in Serum or Plasma
179
877
2.73
22.61
4.7
2.6
umol/l
4344.9
8685.2
0.48
160
736
(3009542) Hematocrit [Volume Fraction] of Blood
348
2390
3.00
21.91
33.3
18.0
%
37.6
38.3
0.63
235
1358
(3032080) INR in Blood by Coagulation assay
261
1555
2.61
21.87
12.8
13.1
inr
1.4
1.5
0.66
56
433
(3030467) Casts [#/volume] in Urine by Automated count
184
928
2.66
21.77
5.7
2.9
e6/l
0.4
0.4
0.03
151
707
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
130
549
2.92
21.68
4.2
2.7
e6/l
0.9
1.0
0.13
83
324
(3027945) Reticulocytes/100 erythrocytes in Blood
126
524
2.95
21.61
3.7
2.0
%
1.8
1.7
0.63
116
455
(3001122) Ferritin [Mass/volume] in Serum or Plasma
223
1243
2.57
21.34
4.3
2.7
ug/l
172.1
161.2
0.28
206
1119
(3002582) Erythrocytes [#/volume] in Urine
196
1029
2.60
21.25
5.7
3.0
e6/l
23.0
157.8
1.44
159
810
(3018095) Leukocytes [#/volume] in Urine
210
1146
2.56
20.91
6.4
3.5
e6/l
112.6
127.1
0.09
169
855
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
230
1311
2.54
20.85
4.7
3.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
207
1127
2.55
20.65
6.2
4.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
190
994
2.57
20.61
2.7
2.2
mg/l
3.2
2.9
0.59
161
840
(40761511) CBC panel - Blood by Automated count
396
2969
3.74
20.56
24.8
16.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
24
5
50.52
20.35
27.5
27.8
ug/l
87.7
125.0
—
19
5
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
77
247
3.55
20.28
6.6
4.0
ng/l
130.1
107.6
0.97
72
210
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
205
1123
2.51
20.03
2.5
2.1
nmol/l
84.9
77.4
3.15
178
951
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
232
1352
2.47
19.73
3.5
3.4
ng/l
4468.1
2169.4
2.40
211
1193
(3013707) Erythrocyte sedimentation rate by Westergren method
323
2193
2.67
19.70
5.7
4.0
mm/h
16.0
14.6
0.73
301
1963
(3002385) Erythrocyte distribution width [Ratio]
328
2244
2.69
19.69
36.4
19.1
%
14.5
13.9
7.32
319
2176
(36304419) Bacteria [Presence] in Urine
172
874
2.56
19.65
5.8
2.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
171
3.97
19.52
3.7
1.4
ug/l
5.1
4.6
0.07
46
133
(3037467) Urinalysis macro (dipstick) panel - Urine
313
2116
2.57
18.88
6.9
4.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
139
650
2.65
18.71
3.0
2.2
mmol/l
2.5
2.4
2.38
120
550
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
358
2616
2.79
17.80
4.9
4.0
mu/l
2.0
2.0
0.27
323
2277
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
305
2069
2.46
17.74
5.7
4.2
ug/l
2.4
2.3
0.11
263
1804
(3007853) Bacteria identified in Skin by Aerobe culture
95
381
2.89
17.06
2.0
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
379
2886
2.96
16.74
6.0
5.5
mmol/l
2.2
2.4
4.20
342
2576
(3020630) Protein [Mass/volume] in Serum or Plasma
84
319
3.01
16.62
2.4
1.7
g/l
65.4
66.4
0.41
72
273
(3018418) pH of Serum or Plasma
175
955
2.36
16.54
8.3
3.1
ph
7.4
7.4
0.04
25
172
(3000991) Gas panel - Venous blood
81
306
3.01
16.15
9.0
6.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
144
729
2.43
16.05
4.6
2.4
e6/l
2.0
3.5
6.16
132
635
(3022217) INR in Platelet poor plasma by Coagulation assay
135
664
2.47
16.03
43.3
33.8
inr
1.7
1.6
0.32
17
91
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
368
2785
2.75
15.97
8.0
7.0
mmol/mol
41.5
42.1
0.61
339
2517
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
194
1120
2.28
15.94
3.4
2.8
ug/l
0.9
0.8
0.30
147
792
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
149
769
2.40
15.88
5.3
4.2
ng/l
312.7
298.2
0.03
140
684
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
355
2660
2.57
15.38
4.7
4.4
mmol/l
1.2
1.2
0.04
311
2343
(3021960) Folate [Moles/volume] in Serum or Plasma
173
964
2.29
15.34
1.8
1.6
nmol/l
21.2
18.7
1.11
147
812
(3023520) Reticulocytes [#/volume] in Blood
93
393
2.72
15.00
3.7
2.2
e9/l
66.8
63.7
0.37
61
316
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
191
1120
2.22
14.86
2.4
2.2
u/l
174.8
304.6
1.12
185
1032
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
364
2788
2.58
14.54
5.3
4.8
mmol/l
3.9
4.1
4.98
331
2507
(3026782) Osmolality of Urine
136
705
2.33
14.11
4.1
2.5
mosm/kgh2o
556.6
573.4
0.49
119
579
(3042936) Bacteria identified in Isolate by Culture
102
466
2.54
13.98
2.1
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
359
2754
2.49
13.91
5.2
4.8
mmol/l
1.3
1.4
4.20
319
2446
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
164
3.45
13.90
2.3
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
28
55
5.36
13.81
2.0
1.7
u/ml
36.0
20.2
0.39
22
43
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
130
667
2.33
13.77
2.4
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
140
3.63
13.70
3.7
2.4
u/ml
0.4
0.4
0.05
28
81
(3044889) 12 lead EKG panel
304
2183
2.20
13.68
5.4
4.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
369
2881
2.54
13.49
6.0
5.2
mmol/l
6.1
6.2
1.55
322
2534
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
52
171
3.31
13.01
2.1
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
198
1226
2.10
12.96
2.5
2.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
97
4.07
12.89
1.8
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
45
137
3.54
12.68
3.0
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
64
244
2.89
12.43
2.3
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
101
489
2.37
12.06
3.9
2.2
mmol/l
0.8
0.8
0.77
93
439
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
281
2024
2.03
11.67
3.7
3.1
pmol/l
15.0
15.1
0.35
250
1760
(40768800) Prostate Pathology biopsy report
19
30
6.57
11.64
1.5
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
82
367
2.51
11.60
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
36
100
3.83
11.58
4.7
3.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
68
280
2.68
11.39
2.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
35
97
3.83
11.30
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
97
3.83
11.30
1.6
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
153
898
2.07
11.23
2.0
1.9
nmol/l
1134.0
1137.2
0.01
107
700
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
241
1672
1.95
10.85
4.5
4.1
%
22.6
25.2
1.37
112
863
(3051611) Lipemic interference index of Serum or Plasma
17
26
6.76
10.71
3.2
3.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
84
395
2.38
10.62
7.2
3.1
mmol/l
1.0
1.8
1.07
71
310
(3009508) Creatinine [Moles/volume] in Urine
177
1115
1.97
10.52
4.9
3.1
mmol/l
6.5
7.8
5.02
144
921
(3012516) Albumin [Mass/volume] in Urine
176
1108
1.97
10.47
5.1
3.2
mg/l
108.3
202.9
0.58
131
765
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
93
460
2.29
10.46
2.3
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
204
2.81
10.07
2.4
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
228
1585
1.89
9.89
3.7
3.0
u/l
56.9
55.1
0.12
210
1424
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
59
244
2.63
9.76
2.1
1.8
g/l
0.2
0.2
0.64
52
208
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
40
134
3.18
9.69
1.7
1.5
g/l
2.4
0.4
0.74
33
111
(3014576) Chloride [Moles/volume] in Serum or Plasma
90
454
2.23
9.61
7.4
5.7
mmol/l
105.0
104.4
0.71
90
437
(3020682) Albumin/Creatinine [Ratio] in Urine
182
1185
1.90
9.60
5.9
4.0
mg/mmol
18.9
9.1
1.79
134
807
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
137
811
1.99
9.58
3.1
2.6
u/l
35.3
38.1
0.30
128
769
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
108
589
2.10
9.45
1.7
1.6
mg/l
2.3
1.4
0.79
77
471
(3037121) Protein [Mass/volume] in Urine
36
116
3.29
9.29
4.7
2.0
g/l
0.3
0.3
0.15
20
41
(3022145) Colonoscopy Study observation
57
238
2.60
9.24
1.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
50
197
2.73
9.09
4.2
3.6
%
0.7
0.9
0.20
18
64
(3000093) Morphology [Interpretation] in Blood Narrative
19
39
5.04
8.91
1.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
89
464
2.14
8.70
2.3
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
128
3.06
8.50
1.7
1.4
g/l
36.4
36.4
0.02
31
100
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
82
421
2.16
8.32
3.1
3.3
ng/l
350.7
311.7
0.26
76
392
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
13
20
6.66
8.11
1.6
1.5
u/ml
7.2
3.4
0.48
13
20
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
149
2.85
8.07
1.7
1.4
g/l
10.4
11.0
0.37
33
120
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
31
5.31
7.98
1.4
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
186
2.64
7.95
4.2
3.7
%
0.1
0.0
0.49
16
57
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
80
3.53
7.93
1.4
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
214
1540
1.74
7.63
4.8
4.7
ng/l
48.8
87.1
0.86
179
1247
(3007164) IgA [Mass/volume] in Serum or Plasma
77
402
2.10
7.45
1.3
1.2
g/l
2.7
3.0
0.32
44
233
(3000494) Fungus identified in Specimen by Culture
64
311
2.23
7.41
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
164
2.65
7.24
1.7
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
164
2.65
7.24
1.7
1.4
g/l
7.1
7.5
0.79
33
115
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
164
2.65
7.24
1.7
1.4
g/l
3.5
3.8
0.91
31
110
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
30
5.14
7.23
1.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
112
3.00
7.21
1.8
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
154
2.68
7.06
1.6
1.5
g/l
3.1
3.2
0.31
31
112
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
27
5.32
7.01
1.7
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
27
5.32
7.01
1.7
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
27
5.32
7.01
1.7
1.2
—
—
—
0
0
(3013512) EKG study
158
1075
1.72
6.68
5.4
4.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
75
3.32
6.52
1.6
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
29
4.95
6.49
1.6
1.1
u/ml
257.6
212.8
—
8
12
(3019225) pH of Specimen
65
335
2.10
6.48
9.7
3.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
41
174
2.49
6.43
3.7
3.8
%
0.2
0.6
—
10
46
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
51
240
2.27
6.36
2.0
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
5
18.32
6.28
1.7
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
199
1463
1.64
6.15
4.4
3.7
estimate
0.0
0.0
0.00
30
255
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
146
992
1.70
6.10
2.6
2.1
u/l
56.9
59.6
0.36
133
914
(3051651) Icteric interference index of Serum or Plasma
10
16
6.37
5.98
4.0
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
90
536
1.85
5.90
6.1
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
28
4.75
5.77
1.4
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
41
4.01
5.76
1.4
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
51
3.63
5.66
2.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
33
4.35
5.59
2.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
436
1.89
5.59
2.3
2.8
ug/l
4.7
6.5
1.39
61
373
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
77
444
1.89
5.57
1.2
1.2
u/ml
0.8
1.7
0.93
13
119
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
47
3.72
5.53
1.8
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
194
1450
1.59
5.42
6.1
5.0
estimate
0.0
0.0
0.00
31
250
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
68
3.19
5.41
1.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
63
3.28
5.38
1.5
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
57
300
2.03
5.36
1.3
1.2
titre
264.0
650.1
—
10
67
(3009261) Glucose [Presence] in Urine by Test strip
197
1481
1.59
5.35
4.5
3.7
estimate
0.0
0.0
0.00
30
250
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
69
3.14
5.29
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
26
4.71
5.29
1.8
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
141
981
1.64
5.26
3.9
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
86
2.89
5.23
2.0
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
172
2.32
5.20
4.2
3.8
%
0.0
0.0
0.49
11
47
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
38
173
2.31
5.13
2.6
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
6
13.54
5.09
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
27
4.54
5.06
1.8
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
27
4.54
5.06
1.8
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
58
314
1.97
5.05
5.6
3.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
36
3.98
5.02
1.1
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
18
56
3.31
4.94
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
107
708
1.67
4.81
4.9
3.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
33
4.03
4.74
1.3
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
51
272
1.99
4.63
5.9
3.8
ph
7.4
7.4
—
5
27
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
64
3.06
4.61
1.7
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
262
1.98
4.42
6.0
3.8
mmol/l
1.6
1.9
0.15
38
188
(3024928) Oxygen saturation in Venous blood
22
83
2.74
4.39
3.6
2.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
15
45
3.41
4.36
3.6
2.8
%
1.8
1.7
—
9
29
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
160
2.22
4.28
2.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
63
2.93
4.11
1.3
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
117
2.39
4.10
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
42
3.41
4.07
1.4
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
42
3.41
4.07
1.4
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
23
94
2.52
3.95
2.9
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
229
1.97
3.94
1.7
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
245
1.93
3.87
2.7
2.5
ml/min/173m2
55.2
55.7
0.03
20
109
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
35
175
2.08
3.80
1.8
1.6
ug/l
3.3
2.0
0.33
25
145
(40768806) Pleura Pathology biopsy report
13
39
3.40
3.79
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
19
72
2.71
3.78
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
25
4.07
3.71
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
25
4.07
3.71
1.2
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
45
3.18
3.68
1.6
1.5
e6/l
51788.4
13602.3
—
8
30
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
56
2.93
3.66
1.6
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
40
3.32
3.65
3.1
3.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
186
2.02
3.60
3.5
3.1
e9/l
3.6
4.0
0.39
20
122
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
9
7.88
3.57
4.6
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
41
3.24
3.52
8.5
3.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
36
3.40
3.50
3.9
2.5
%
59.0
56.3
—
5
21
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
70
2.64
3.42
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
70
2.64
3.42
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
53
2.89
3.39
1.4
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
43
3.08
3.27
1.6
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
7
8.67
3.27
20.0
6.4
mmol/l
11.5
6.7
—
6
7
(40768795) Lymph node Pathology biopsy report
6
7
8.67
3.27
1.2
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
7
8.67
3.27
1.0
1.4
e9/l
0.1
0.2
—
6
7
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
22
98
2.31
3.18
2.6
2.5
pmol/l
4.1
4.2
0.27
17
83
(3023199) Leukocytes [#/volume] in Pleural fluid
14
50
2.86
3.11
1.6
1.5
e6/l
2682.0
2109.0
—
8
36
(21494890) Protein electrophoresis panel - 24 hour Urine
12
40
3.05
2.99
2.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
185
1.91
2.96
2.5
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
94
672
1.50
2.96
1.3
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
11
35
3.20
2.95
1.2
1.4
—
18.7
—
0
7
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
371
1.65
2.94
4.6
3.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
31
166
1.93
2.84
7.2
4.3
mmol/l
25.3
24.9
0.37
26
148
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
47
2.82
2.84
1.5
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
71
2.45
2.83
1.4
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
11
36
3.11
2.82
1.8
1.6
u/ml
9.7
108.5
0.97
11
29
(44806118)
10
31
3.28
2.79
1.3
1.3
—
—
—
0
0
(44790047)
10
31
3.28
2.79
1.3
1.3
—
—
—
0
0
(44790048)
10
31
3.28
2.79
1.3
1.3
—
—
—
0
0
(44790049)
10
31
3.28
2.79
1.3
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
6
8.41
2.75
1.4
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
87
2.24
2.61
3.4
2.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
15
4.72
2.60
1.1
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
38
2.94
2.60
2.0
2.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
28
150
1.92
2.58
1.1
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
7
7.21
2.55
1.8
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
39
2.87
2.49
1.7
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
33
190
1.80
2.45
2.1
2.1
nmol/l
11.8
14.5
0.86
24
154
(3045788) Cell count panel - Pleural fluid
11
40
2.79
2.39
1.7
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
84
2.19
2.38
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
156
1.85
2.31
1.1
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
209
1.73
2.31
2.3
1.8
ug/g
228.4
174.2
0.29
23
164
(3042631) Mycobacterium sp identified in Specimen
11
41
2.73
2.29
2.9
2.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
15
67
2.28
2.20
1.1
1.0
—
76.7
—
0
6
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
14
4.33
2.15
1.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
14
4.33
2.15
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
34
206
1.70
2.14
6.8
4.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
124
1.90
2.11
4.0
3.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
31
2.94
2.08
1.1
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
10
5.04
2.07
1.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
15
4.04
2.04
5.5
1.3
u/l
199.0
201.2
—
6
15
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
15
4.04
2.04
2.8
3.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
44
2.54
2.02
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
57
2.32
1.99
2.2
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
91
697
1.38
1.97
1.8
1.6
mmol/l
1.2
1.2
0.31
81
552
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
11
4.58
1.94
1.2
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
39
2.60
1.93
4.8
2.1
e9/l
5.6
5.3
—
10
39
(3045414) Leukocytes [Presence] in Urine
19
99
1.96
1.93
1.8
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
107
1.91
1.89
1.5
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
65
473
1.44
1.88
6.3
5.7
mmol/l
0.0
1.4
2.36
51
357
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
34
2.68
1.87
6.0
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
28
2.89
1.87
1.1
1.0
—
—
—
0
0
(44806420)
6
17
3.56
1.84
1.8
2.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
12
4.20
1.83
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
12
4.20
1.83
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
12
4.20
1.83
1.4
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
35
2.60
1.81
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
57
408
1.45
1.80
5.1
5.2
%
31.1
33.7
1.32
39
272
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
29
2.79
1.80
1.0
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
19
102
1.90
1.79
3.6
2.9
kpa
8.1
7.6
0.78
19
92
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
41
2.47
1.76
4.9
2.5
%
64.3
61.9
—
10
41
(4010399)
33
211
1.61
1.73
1.4
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
2.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
2.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
2.3
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
13
3.88
1.72
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
13
3.88
1.72
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
13
3.88
1.72
1.2
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
19
3.19
1.66
1.5
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
25
2.83
1.65
1.6
1.3
ug/l
13.2
15.9
—
7
25
(3011648) Oxygen content in Venous blood
7
25
2.83
1.65
3.3
1.8
%
8.9
10.3
—
7
25
(21494434) Karyotype in Bone marrow
10
43
2.36
1.61
1.2
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
37
248
1.54
1.61
2.2
1.6
nmol/l
344.6
355.0
0.13
31
217
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
15
3.36
1.52
1.8
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
15
3.36
1.52
1.8
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
86
1.89
1.52
3.4
1.9
g/l
127.6
131.8
—
10
65
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
27
2.62
1.52
1.6
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
382
1.41
1.45
1.3
1.2
iu/ml
105.0
41.6
0.88
13
122
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
59
2.06
1.44
2.1
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
59
2.06
1.44
1.4
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
29
190
1.56
1.41
3.9
2.5
%
0.6
0.7
0.61
29
183
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
46
2.20
1.41
2.3
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
60
2.03
1.39
4.7
2.3
%
66.4
64.3
0.10
12
60
(3000475) Leukocytes [#/volume] in Synovial fluid
15
82
1.86
1.37
1.3
1.4
e6/l
22924.8
19861.5
—
10
59
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
23
2.63
1.37
2.3
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
17
2.96
1.36
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
170
1.56
1.29
2.5
3.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
139
1.61
1.25
1.4
1.4
—
51.9
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
56
1.99
1.23
2.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
19
2.65
1.22
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
19
2.65
1.22
1.8
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
26
2.32
1.19
1.0
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
363
1.36
1.16
1.3
1.2
u/ml
1.4
12.0
2.26
13
119
(3014271) Vancomycin [Susceptibility]
7
30
2.35
1.12
4.1
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
88
1.73
1.12
6.3
3.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
67
1.81
1.05
1.6
1.5
ug/g
344.2
256.1
—
6
43
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.4
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.0
—
593.2
—
0
19
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.0
—
351.0
—
0
19
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
29
0.00
0.98
0.0
1.0
—
45.2
—
0
18
(4094501)
12
69
1.76
0.97
1.3
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
50
1.82
0.97
1.7
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
6
27
2.24
0.93
2.2
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
6
27
2.24
0.93
3.3
1.4
u/ml
22.2
51.8
—
6
27
(1761482) Bacteria [#/volume] in Urine by Culture
17
110
1.57
0.92
2.6
4.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
29
2.08
0.89
3.8
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
11
64
1.74
0.87
2.3
1.6
mmol/l
1.5
1.8
0.65
11
64
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
29
215
1.37
0.83
1.4
1.7
%
1.7
1.9
0.11
22
166
(3020491) Glucose [Moles/volume] in Blood
0
25
0.00
0.79
0.0
4.2
—
7.5
—
0
19
(4034850)
7
125
0.55
0.78
24.1
10.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
192
1.38
0.77
10.9
8.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
34
1.77
0.76
1.8
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
59
1.71
0.76
1.1
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
130
1162
1.17
0.76
5.1
4.0
—
—
—
0
0
(4024509)
5
24
2.10
0.74
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
60
1.68
0.72
2.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
55
456
1.23
0.72
12.2
8.1
—
—
—
0
0
(1002224) Polysomnography panel
9
57
1.59
0.71
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.8
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
206
1.33
0.67
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
78
1.55
0.66
1.1
1.6
—
—
—
0
0
(3000492) Spirometry study
25
189
1.34
0.66
2.0
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
2.8
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
63
1.60
0.62
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
29
230
1.28
0.57
7.2
2.8
mmol/l
24.6
25.1
0.37
29
223
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
36
1.68
0.57
1.3
1.1
nmol/l
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
5
90
0.55
0.56
3.6
4.1
mg/l
20.2
29.8
—
5
70
(3021788) Differential panel - Synovial fluid
10
65
1.55
0.56
1.5
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
61
1.48
0.54
4.3
2.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
63
1.44
0.52
4.3
2.3
mmol/l
4.2
4.1
—
9
63
(3035285) Chloride [Moles/volume] in Venous blood
9
63
1.44
0.52
4.3
2.3
mmol/l
106.2
105.1
—
9
63
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
83
1.46
0.52
1.2
1.1
iu/ml
173.4
94.3
—
6
30
(3022621) pH of Urine by Test strip
28
225
1.26
0.51
2.7
3.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
47
1.50
0.47
1.3
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
50
1.41
0.45
1.9
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
95
1.38
0.44
1.2
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
32
1.57
0.42
1.0
1.4
—
—
—
0
0
(4027681)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
34
1.48
0.40
1.0
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.1
—
150.1
—
0
18
(3041096) Erythrocytes [Presence] in Urine by Automated
84
764
1.12
0.40
4.0
3.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
67
731
0.90
0.30
3.6
3.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
93
866
1.09
0.30
1.9
1.9
pmol/l
395.1
8154920.7
0.50
73
699
(3019832) Treponema pallidum Ab [Presence] in Serum
8
62
1.30
0.28
2.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
73
0.68
0.26
1.0
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
75
1.20
0.25
1.2
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
5
38
1.32
0.23
4.6
2.4
ml
958.0
573.5
—
5
24
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
163.3
—
0
12
(3000764) Benzodiazepines [Presence] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
28
312
0.89
0.20
3.2
4.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
51
1.18
0.19
1.7
1.6
%
88.3
89.2
—
6
51
(3029937) Albumin [Presence] in Urine by Test strip
90
855
1.07
0.19
5.9
3.9
estimate
0.0
0.0
0.00
30
232
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
59
1.19
0.18
1.1
1.1
—
26.7
—
0
5
(3040151) Glucose [Moles/volume] in Capillary blood
7
63
1.11
0.17
2.4
8.0
mmol/l
5.7
7.6
—
7
49
(3043409) Potassium [Moles/volume] in Arterial blood
15
133
1.13
0.12
3.2
4.1
mmol/l
4.0
4.0
0.01
15
119
(3018405) Lactate [Moles/volume] in Arterial blood
18
163
1.11
0.11
2.9
3.8
mmol/l
1.7
1.6
0.13
18
158
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
74
722
1.03
0.06
5.9
4.1
kg/l
1.0
1.0
0.27
16
123
(3010421) pH of Blood
12
110
1.09
0.05
7.5
4.4
ph
7.4
7.4
0.38
12
94
(3020891) Body temperature
17
181
0.94
0.05
3.8
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
255
1.02
0.00
1.9
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
253
0.99
0.00
6.9
3.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
2.0
—
1.2
—
0
8
(3028707) Methadone [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.1
—
0
7
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
69
1.01
0.00
1.6
1.3
nmol/l
0.6
0.8
—
7
62
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
9.6
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EAR_EXALLC – Carcinoma in situ of skin of ear and external auricular canal
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).